ABRDN PLC – Horizon Therapeutics Public Limited Company Transaction History
ABRDN PLC portfolio value:
$118.57M
portfolio value
ABRDN PLC quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.75% | -183.60K shares | -52.12M | $61.89 | 1.91M |
| Q2 2022 | share | Increase | +0.52% | 10.79K shares | -50.53M | $79.76 | 2.09M |
| Q1 2022 | share | Increase | +14.11% | 258.34K shares | 23.99M | $105.21 | 2.08M |
| Q4 2021 | share | Decrease | -2.27% | -42.48K shares | -7.91M | $108.26 | 1.83M |
| Q3 2021 | share | Increase | +3.10% | 56.26K shares | 34.94M | $109.54 | 1.87M |
| Q2 2021 | share | Increase | 0.00% | 1.81M shares | 170.21M | $93.64 | 1.81M |
| Q1 2021 | share | Increase | +7.65% | 134.63K shares | 45.65M | $92.04 | 1.89M |
| Q4 2020 | share | Decrease | -13.94% | -284.97K shares | -30.16M | $73.15 | 1.75M |
| Q3 2020 | share | Decrease | -3.71% | -78.73K shares | 40.93M | $77.68 | 2.04M |
| Q2 2020 | share | Decrease | -6.44% | -146.24K shares | 50.71M | $55.58 | 2.12M |
| Q1 2020 | share | Increase | +23.36% | 429.8K shares | 626K | $29.62 | 2.26M |
| Q4 2019 | share | Increase | +23.19% | 346.32K shares | 25.91M | $36.2 | 1.83M |
| Q3 2019 | share | Increase | 0.00% | 1.49M shares | 40.68M | $27.23 | 1.49M |